Clinical Trials Directory

Trials / Completed

CompletedNCT04492189

Containment Measures and Eating Disorders

Impact of Containment Measures in People With Eating Disorders: a Descriptive Study

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
University Hospital, Montpellier · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Since March 17, 2020, the French government has implemented national containment measures due to the COVID-19 epidemic. Quarantine is an unpleasant experience : Separation from relatives, loss of liberty, concern about the infectious status, boredom, can negatively affect mental health, with the emergence of anxiety and depressive symptoms. In addition, confinement can disrupt usual physical activity, a major destabilization criterion for patients suffering from eating disorders (ED). Finally, conditions of confinement can harm social support, yet identified as a protective and resilience factor in stress contexts. Thus, the current context of confinement and social distances could be source of an increase in eating behavior disorders symptoms in people suffering from ED.

Detailed description

Investigators will recruit 40 patients with eating disorders. All patients were initially assessed in the daily hospital of the Endocrinology, Diabetes, Nutrition Department (Montpellier University Hospital) from January to march 2020. All participants will performed a phone interview to assess eating disorder symptoms, caracteristicus of containment, 1 month after the beginning of the containment, and 1 month after the end of the containment.

Conditions

Timeline

Start date
2020-04-01
Primary completion
2020-05-30
Completion
2020-06-30
First posted
2020-07-30
Last updated
2020-07-30

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04492189. Inclusion in this directory is not an endorsement.